Medical Technology Venture Partners reported raising $20 million for its maiden $50 million fund.
The San Francisco-based VC shop said in a regulatory filing that it raised the cash from 20 unnamed investors.
The fund is managed by Radu Cautis, according to a March 24 regulatory filing, whose LinkedPage lists him as an angel investor and former Gambro Renal employee (Baxter (NYSE:BAX) paid $4 billion for the Swedish dialysis giant in September 2013).
Cautis has a Twitter feed but has never used it for a public Tweet. A link on his Twitter page to raducautis.com lists Cautis as “[i]nvesting in and advising to startups.”
“Previously involved in private equity and held various executive roles at a med tech company including VP of South East Asia & India, VP of Strategy, and VP of Marketing,” the website reads.
did not respond to a request for comment declined to comment April 5 via LinkedIn.